MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) gene has been identified as an oncogene transcriptionally activated by t(6;14)(p25;q32) chromosomal translocation in multiple myeloma (MM). 
Introduction

The 14q
+ chromosome (14q + ), which represents chromosomal translocations involving the immunoglobulin heavy chain gene (IgH) locus located at 14q32.33, is thought to play a crucial role during the early stages of multiple myeloma (MM). [1] [2] [3] It has been demonstrated to exist in more than half of the cases with monoclonal gammopathy of undetermined significance (MGUS), which is believed to precede a fraction of MM. 4 A few candidate oncogenes such as Cyclin D1, FGFR3 and MMSET, MUM1/IRF4 and c-MAF, which are deregulated by virtue of their juxtaposition to IgH loci, have been identified. [5] [6] [7] [8] [9] [10] Additional reports have revealed the simultaneous presence of multiple 14q
+ in each MM cell, 10, 11 which suggests that 14q + may also contribute to the later stages of progression during tumorigenesis. For these reasons, it is important to understand the function of the oncogene activation produced by the distinct presence of 14q + in MM. Recently we demonstrated that the MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) gene, which is located at chromosome 6p25 and encodes for a lymphocyte specific IRF family protein essential for both lymphocyte activation and B cell differentiation, is implicated in the pathogenesis of MM. 9, 12, 13 To investigate the significance of t(6;14)(p25;q32), which is cryptic for conventional cytogenetic analysis, we developed diagnostic procedures using double color fluorescence in situ hybridization (DCFISH) and pulsed-field gel electrophoresis (PFGE) analysis followed by their application to the examination of MM samples. 
Materials and methods
MM cell lines and samples
A total of 17 MM cell lines (RPMI8226, U266, EJM, SK-MM-1, XG-1, XG-2, XG-4, XG-5, XG-6, XG-7, XG-10, FR4, ODA, NOP-1, KM-5, ILKM-8, JJN3) were studied. 9, [14] [15] [16] Human recombinant interleukin-6 provided by Kirin Brewery Corporation (Tokyo, Japan) was used for the culture of the IL-6-dependent MM cell lines. Thirty-eight patients with MM, whose tumor cell percentage exceeded 12.1% of the total nucleated cells in bone marrow aspirates before chemotherapeutic regimens were started, were included in this study after their informed consent had been obtained.
Construction of the PAC conting surrounding the MUM1 gene
Initial PAC clones containing the MUM1 gene were isolated from a human PAC library purchased from Genome Systems (St Louis, MO, USA) by means of hybridization screening using full-length MUM1 cDNA probes. 9 Genomic walking was performed by using the PAC-end probes isolated by the modified bubble-PCR method from those for YAC-end isolation. 17 
PFGE
An agarose plug containing 1 × 10 6 cells was digested with the NotI restriction enzyme and run on to a 0.5 × TBE, 1% agarose gel. PFGE was performed with the aid of the CHEF DR II system (BIo-Rad, Richmond, CA, USA) as previously described. 17 Genomic probes isolated from the MUM1 locus (as shown in Figure 1a ) and a 4.0 kb Bam HI/XhoI IgC␣ probe (gift from Dr V Bertness, National Cancer Institute, Bethesda, MD, USA) were used to detect genomic rearrangements at these loci.
Northern analysis
Northern blot analyses were performed as previously described. 9, 17 Ten micrograms of the total RNA isolated with the guanidine isothiocyanate/cesium chloride ultracentrifugation method was loaded on to each lane. 2.1 H MUM1 probe was used to validate the expression of the MUM1 mRNA and ␤-actin probe to control the quantity of RNA loaded on to each well.
9 MUM1 mRNA levels were quantified after normalization against ␤-actin RNA level using a densitometric analysis.
Figure 1
Chromosomal rearrangements at the 6p25 locus, which result in overexpression of the MUM1 mRNA, involved in MM with t(6;14)(p25;q32). (a) A 400 kb PAC contig containing approximately 260 kb at 5Ј and 140 kb at 3Ј distance from the MUM1 gene. N indicates NotI restriction enzyme sites, and N* the NotI site, which is resistant to digestion in the majority of cell plugs derived from normal volunteers. The black box and the shaded boxes indicate, respectively, the MUM1 gene and genomic probes used for PFGE analysis. Arrows denote the location of the breakpoints involved in t(6;14)(p25;q32) of the SK-MM-1, XG-7 and FR4 cell lines. 
DCFISH
Chromosome preparation and the basic method of DCFISH have been described previously. 18 The signal detection system using fluorescein isothiocyanate (FITC) and tetramethylrhodamine isothiocyanate (TRITC) with counterstaining of 4Ј, 6-diaminido-2-phenylindole dihydrochloride (DAPI) has been described previously. 4, 17 The probes used in this study consisted of Alu-PCR-derived DNA fragments from a YAC clone, Y6, and a bacteriophage clone, Ig␥1-10 containing, respectively, the variable region (VH) and the C␥1 region of the IgH gene, 4, 18 PACs 61b14 and 120i21 mapped at the MUM1 locus (Figure 1a) . For the interphase DCFISH, signals were evaluated in 100 to 200 nuclei per slide containing combinations of 61b14/Ig␥1-10 and 120i21/Y6. Cut-off indices to assess fusion signals were determined by evaluating five bone marrow samples derived from five normal volunteers.
Results and discussion
MUM1 gene at 6p25 locus juxtaposes to IgC␣ locus as a result of t(6;14)
A 400 kb PAC contig spanning the MUM1 gene was constructed and NotI sites were mapped as shown in Figure 1a . The DNA agarose plugs derived from peripheral blood of 11 normal volunteers were digested and analyzed by PFGE using four genomic probes which can detect different NotI fragments. It was demonstrated that the NotI site shown as N* in Figure 1a was resistant to digestion in all of the normal samples tested, probably due to epigenetic modifications such as methylation, leading to the generation of a 400 kb germline band detected by the 2.5 EH probe. However, in some MM cell lines such as SK-MM1 and XG-7, this NotI site became digestible, resulting in the appearance of a 160 kb extraband (Figure 1b) . Among our panel of 17 MM cell lines, PFGE analysis showed abnormal, rearranged bands in three of them (17.6%), SK-MM1, XG-7 and FR4, and indicated that the locations of the breakpoints were within the 400 kb NotI fragment. The bands of XG-7 and FR4 comigrated with rearranged bands detected by the C␣ probe, this indirectly showing the juxtaposition of the MUM1 gene with 3Ј ␣ enhancers (3Ј␣E) within approximately 350 kb for XG-7 and 780 kb for FR4. These locations are close enough for the MUM1 expression to be influenced by the 3Ј␣E as in the cases of t(11;14) and t(14;16), which are associated with MM displaying overexpression of, respectively, Cyclin D1 and c-MAF. 5, 10, 14, 19 In parallel with these translocations, the MUM1 mRNA was overexpressed in the three lines carrying MUM1 rearrangements six to eight times more than in the control MM lines (Figure 1c) .
In XG-7, the 120i21-SP6 probe ( Figure 1a) detected a rearranged band different in size from that detected by the 2.5 EH probe (data not shown), which demonstrated the presence of the breakpoint between these two loci used as probes.
DCFISH analysis is a powerful tool for the detection of t(6;14) translocations
As probes for FISH, we used two PACs DNAs mapped at 5Ј (61b14) and 3Ј (120i21) to the MUM1, since all of the other PAC DNAs crosshybridized to the 16p11, as well as to 6p25 locus. Using two PACs, as well as Y6, and Ig␥1-10 DNAs for DCFISH analysis, t(6;14) could be identified in the form of a yellow fusion signal. The data from the PFGE analysis showed that the same three MM lines harbored the MUM1/IgH fusion signals (Figure 2 ). On the metaphase spreads of the XG-7 cells, signals generated by 120i21 were split into 6p25 and 14q32, indicating that the translocation occurred within this PAC (Figure 2a) . One of those signals fused with the one detected with the Ig␥1-10 probe on the der (14) , which confirms that the MUM1 moved to the 14q32 locus as in a case of the SK-MM1 cell line. 9 On the other hand, all of the fusion signals formed by 61b14 and Y6, 120i21 and Y6, and 120i21 and Ig␥1-10 were observed on chromosome 6p25 in the FR4 cells (Figure 2b and data not shown), indicating that the MUM1 remained at 6p25. This finding, together with the data from the PFGE analysis, indicates that the IgH sequences encompassing the VH to CH regions is inserted at either 5Ј or 3Ј to the MUM1 gene. We next explored the frequency of t(6;14) in MM samples. Because of the low mitotic index of the MM cells, interphase DCFISH employing pairs of 61b14/Ig␥1-10 and 120i21/Y6 probes, was used. The fusion signals when these probes were used in controls were 6.7 ± 1.8 and 6.8 (6;14) in patients with MGUS whose tumor percentage in marrow sample is less than the cut-off values of this analysis. This technical problem needs to be improved to explore the significance in early stage myelomas. In this study, a comparison of clinical parameters such as Ig isotype, hemoglobin level, serum creatinine level, stage and bone involvement between fusion-positive and negative cases did not show any statistically significant differences (data not shown). However, further studies will be needed to clarify the effect of the t(6;14) on the prognosis for and response to chemotherapy or interferons, since the patients included in our study were treated with heterogeneous chemotherapeutic regimens.
In conclusion, we detected the MUM1-IgH fusions as consequences of the t (6;14) or IgH insertion into the MUM1 locus in 17.6% (3/17) of the MM cell lines and in 21.1% (8/38) of the primary MM samples by means of either PFGE or DCFISH analyses. These diagnostic procedures will be useful when applied to large series of clinical trials against MM to evaluate the clinical significance of this specific gene alteration.
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